Developing therapies for the mankind’s health needs has come a long way since the early days of infectious disease control. In the last 5 decades, especially, “global health” has become a well-established area of work, with millions of committed scientists and healthcare workers supported by hundreds of billions of dollars in investment from donors. The results have been nothing short of a miracle: maternal and child mortality rates have plummeted and infectious diseases no longer kill tens of millions during each outbreak. The success has been possible because of the innovation in health technologies in the west and their implementation in communities that needed them. However, there is an increasing awareness in the field that perhaps the benefits can and should be greater than what we have seen so far, that we must accelerate the pace of impact, and that here is perhaps a need to rethink how we develop innovative healthcare solutions for global health. This seminar outlines a new paradigm in global health innovation – reciprocal innovation – that builds upon ideas in other disciplines. The central tenet of reciprocal innovation is collaborative engagement of all stakeholders (especially the beneficiary communities) from the needs finding and concept development stage to translation of the concepts into viable solutions and implementation and scale up of these solutions. The speaker lays out a framework for reciprocal innovation in global health in this interactive session, with the hope of a lively discussion with the audience that strengthens and advances the framework.
About the Speaker:
Dr. Anurag Mairal, PhD, MBA, Consulting Associate Professor of Medicine and the Director, Global Exchange Program at Stanford Byers Center for Biodesign, is a co-founder and Executive Vice President of Orbees Medical, a market research and strategy solutions firm based in the SF Bay Area and focused on the medtech industry. In this role, he oversees engaging with key stakeholders in the industry including senior executives of the medtech multinationals, thought leaders in medicine, and marketing and sales organizations. Dr. Mairal also serves as a consulting associate professor at the Stanford University School of Medicine and as the director of global exchange at Stanford’s Biodesign program.
Dr. Mairal has an extensive background in medical device development, collaborating with partners in India, China, and other emerging markets to advance product development, manufacturing, and distribution. Recently, Dr. Mairal took two years off from Orbees Medical to take a senior leadership role at PATH, a major global health nonprofit based in Seattle. In this role, he oversaw research and development, commercialization, and implementation of technologies in PATH’s medical devices, diagnostics, and digital health divisions. Previously, he held several positions at Johnson & Johnson, including Business Development Director and Product Director for structural heart, cardiology, and peripheral vascular products at Cordis.
Dr. Mairal earned a PhD in chemical engineering from the University of Colorado at Boulder and an MBA from the University of California at Berkeley. He also holds an MS in chemical engineering from the Indian Institution of Technology in Mumbai and a BS in chemical engineering from National Institute of Technology, Raipur. His work has been published in more than 30 publications, and he has been issued seven patents.
Title images are licensed under Creative Commons License.